American Portfolios Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $21.4K | Hold |
1,700
| – | – | ﹤0.01% | 2153 |
|
|
2022
Q2 | $18K | Hold |
1,700
| – | – | ﹤0.01% | 2279 |
|
|
2022
Q1 | $27.6K | Hold |
1,700
| – | – | ﹤0.01% | 2203 |
|
|
2021
Q4 | $23.5K | Sell |
1,700
-35,000
| -95% | -$485K | ﹤0.01% | 2253 |
|
|
2021
Q3 | $527K | Sell |
36,700
-300
| -0.8% | -$4.31K | 0.02% | 677 |
|
|
2021
Q2 | $585K | Buy |
37,000
+850
| +2% | +$13.4K | 0.02% | 648 |
|
|
2021
Q1 | $368K | Buy |
36,150
+17,650
| +95% | +$180K | 0.02% | 784 |
|
|
2020
Q4 | $138K | Buy |
18,500
+16,741
| +952% | +$125K | 0.01% | 1028 |
|
|
2020
Q3 | $6.04K | Buy |
1,759
+759
| +76% | +$2.61K | ﹤0.01% | 2193 |
|
|
2020
Q2 | $4.77K | Buy |
+1,000
| New | +$4.77K | ﹤0.01% | 2261 |
|